A Phase 2 trial of CAD-1883 for treatment of spinocerebellar ataxia
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2019
Price : $35 *
At a glance
- Drugs CAD-1883 (Primary)
- Indications Spinocerebellar ataxias
- Focus Therapeutic Use
- 17 Oct 2019 According to a Saniona media release, the company plans to file an IND to initiate this study in patients with SCA by year end 2019.
- 02 Dec 2018 New trial record
- 15 Nov 2018 According to a Saniona media release, the is planning to start the trial in the second half of 2019.